Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    23289822 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Comparing the Metabolic Control of Once to Twice-daily Insulin Detemir Injections
Condition: Type 1 Diabetes Mellitus
Interventions: Drug: Levemir (insulin detemir);   Drug: Levemir twice a day

Indicates status has not been verified in more than two years